CNBC Cures: A dad and a doctor on how raising a child with Angelman syndrome changed him

8 hours ago

Novo Nordisk's Wegovy pill launch draws a new wave of patients into GLP-1s

8 hours ago

Trump admin finalizes better-than-feared Medicare Advantage payment rate

2 days ago

FDA declines to issue specific guidance on health programs' foreign drug imports

3 days ago

Trump administration sets up to 100% tariffs on some imported drugs

3 days ago

Novo Nordisk says Wegovy pill outperforms Lilly's oral GLP-1 in cross-trial comparison

7 days ago

Eli Lilly opposes White House push to codify most favored nation drug pricing

7 days ago

FDA approves Eli Lilly's GLP-1 pill, opening next phase for weight loss drugs

8 days ago

Stocks soar on hopes of war resolution — plus, Lilly takes a swing in sleep disorders

8 days ago

Lilly to spend up to $7.8 billion to acquire Centessa, sleep disorder drugmaker

9 days ago

Novo Nordisk launches Wegovy subscriptions as it tries to catch up with Eli Lilly

9 days ago

Eli Lilly reaches deal to bring AI-developed drugs to global market

9 days ago

AstraZeneca stock jumps after surprise lung disease trial win

11 days ago

Pfizer to seek approval for Lyme disease vaccine candidate despite trial miss

13 days ago

Danone to buy protein shake maker Huel as health nutrition craze drives demand shift

17 days ago

The price of menstrual products is skyrocketing from inflation, tariffs

18 days ago

GLP-1 drugs are changing how Americans eat. Food companies are racing to catch up

19 days ago

How CNBC Cures is bringing rare disease stories to a national audience

20 days ago

FDA approves higher-dose version of Novo Nordisk's obesity drug Wegovy

20 days ago

9% of ACA health-care plan enrollees uninsured after enhanced subsidies expire: Poll

21 days ago

Eli Lilly's obesity drug retatrutide clears first late-stage diabetes trial

21 days ago

Stopping GLP-1s raises risk of heart attack, stroke and death, study says

21 days ago

FDA approves psoriasis pill from J&J that rivals shots Tremfya, Skyrizi

22 days ago

Eli Lilly shares slide after a bearish Wall Street analyst call — here's our view

23 days ago

Trump says White House chief of staff Susie Wiles has breast cancer

23 days ago

Vertex passes key test in quest to treat kidney diseases

30 days ago

FDA approves leucovorin as first drug for rare genetic disorder

30 days ago

Hims & Hers shares surge after Novo Nordisk drops patent infringement case

30 days ago

Inside the booming business of wellness third spaces and membership clubs

1 month ago

FDA vaccine head will step down in April after string of controversial decisions

1 month ago

FDA reversals leave investors worrying about the fates of other experimental drugs

1 month ago

FDA official calls UniQure's gene therapy a 'failed' treatment for Huntington's

1 month ago